Clinical Trials Sponsored by Agensys, Inc.

Total 37032 results

Environmental Protection Agency (EPA)

Completed

Cardiovascular Effects of Incremental Diesel Exhaust Inhalation in Middle-Aged Healthy GSTM1 Null Human Volunteers

Healthy

United States
International Atomic Energy Agency

Completed

Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer

Head and Neck Cancer
British Columbia Cancer Agency

Completed

Bone Health in Gynecologic Cancers-does FOSAVANCE Help? (FOSAVANCE)

Ovarian Cancer

Canada
British Columbia Cancer Agency

Completed

Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial

Advanced Colorectal Cancer

Canada
British Columbia Cancer Agency

Recruiting

177Lu-HTK03170 in mCRPC With PSMA Positive Disease

Prostate Cancer Metastatic | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate Cancer

Canada
British Columbia Cancer Agency

Recruiting

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases

Pathologic Processes | Neoplasms | Neoplasm Metastasis | Neoplastic Processes

Canada
British Columbia Cancer Agency

Recruiting

DOTATOC PET/CT for Imaging NET Patients

Pituitary Adenoma | Neuroendocrine Tumors | Medulloblastoma | Small-cell Lung Cancer | Neuroblastoma | Meningioma | Merkel Cell Carcinoma | Pheochromocytoma | Paraganglioma | Gastrinoma | Glucagonoma | Insulinoma | Vipoma | Carcinoid | Ganglioneuroma | Medullary Carcinoma

Canada
British Columbia Cancer Agency

Recruiting

Partial Prostate Salvage High Dose Rate Brachytherapy (SalvageHDR)

Recurrent Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer (TAPER)

Endometrial Cancer

Canada
British Columbia Cancer Agency

Active, not recruiting

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

Prostate Cancer

Canada
British Columbia Cancer Agency

Approved for marketing

18F-FDG PET Imaging in Cardiac Sarcoidosis

Cardiac Sarcoidosis

Canada
British Columbia Cancer Agency

Active, not recruiting

68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

Neoplasms | Urogenital Neoplasms | Disease Attributes | Prostate Cancer | Prostatic Neoplasm | Prostatic Disease

Canada
British Columbia Cancer Agency

Completed

Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases (Amadeus)

Brain Metastases

Canada
British Columbia Cancer Agency

Completed

US-CT Fusion for Post Implant Dosimetry

Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

A Randomized Placebo-Controlled Trial of Manuka Honey for Oral Mucositis Due to Radiation Therapy for Cancer

Head and Neck Cancer | Radiotherapy Induced Mucositis

Canada
British Columbia Cancer Agency

Terminated

Intraprostatic MAXimal Simultaneous Boost

Prostate Cancer

Canada
British Columbia Cancer Agency

Unknown

C-arm Cone-beam CT in Prostate Brachytherapy (C-arm)

Prostate Cancer

Canada
British Columbia Cancer Agency

Unknown

Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy (FTPC)

Prostate Cancer

Canada
International Atomic Energy Agency

Completed

Optimization of Radiotherapy in Treatment of Painful Bone Metastasis (bone mets)

Pain | Bone Metastasis

Egypt, Spain, Serbia, Algeria, Brazil, India, Lithuania, Macedonia, The Former Yugoslav Republic of, Mexico, Tunisia, United Kingdom
British Columbia Cancer Agency

Completed

Feasibility of VMAT and CBCT for Head and Neck Carcinomas

Head and Neck Carcinoma

Canada
British Columbia Cancer Agency

Completed

Can 3D Ultrasound Be Used Reproducibly by Radiation Therapists in Partial Breast Image-Guided Radiation Therapy (IGRT)

Radiation Therapy for Primary Breast Cancer

Canada
International Atomic Energy Agency

Completed

CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy

Cervix Cancer

Peru, Korea, Republic of, Morocco, Austria, Brazil, Canada, India, Macedonia, The Former Yugoslav Republic of, Pakistan, South Africa, United Kingdom
International Atomic Energy Agency

Completed

Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia

Esophageal Cancer

China, Canada, Croatia, India, Pakistan, South Africa, Thailand
Environmental Protection Agency (EPA)

Completed

Cardioprotective Effects of Omega-3 Fatty Acids Supplementation in Healthy Older Subjects Exposed to Air Pollution Particles

Healthy

United States
British Columbia Cancer Agency

Completed

Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy

Hormone Refractory Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

Acupuncture in Palliative Cancer Care

Neoplasms | Palliative Care

Canada
British Columbia Cancer Agency

Completed

A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer

Adenocarcinoma of the Prostate

Canada
Genesys
Novo Nordisk A/S

Completed

The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit

Sepsis | Respiratory Failure | Renal Failure | Surgical Site Infection

United States
British Columbia Cancer Agency

Recruiting

Evidence Development in Cancer Treatment - Real World: PREDiCTrw

Cancer

Canada
British Columbia Cancer Agency

Not yet recruiting

Diagnostic CT Palliative Radiotherapy: Feasibility Study of Treating Bone Metastases Without a CT Simulation (dCT-PRT)

Bone Metastases
British Columbia Cancer Agency

Not yet recruiting

Preliminary Assessment of [18F]BL40 in PET/CT Scans

Multiple Myeloma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma

Canada
British Columbia Cancer Agency

Not yet recruiting

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

B-cell Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-Cell Leukemia | B-cell Acute Lymphoblastic Leukemia | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | High-grade B-cell Lymphoma

Canada
British Columbia Cancer Agency

Recruiting

CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease

Non Small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal Metastasis

Canada
International Atomic Energy Agency

Recruiting

FDG an Myocardial Infarction: The PIAF Trial (PIAF)

History of Myocardial Infarction

United States
British Columbia Cancer Agency

Recruiting

A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer

Ovarian Cancer | Platinum-resistant Ovarian Cancer

Canada
British Columbia Cancer Agency

Recruiting

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) (PROMPT)

Oligometastatic Prostate Cancer

Canada
British Columbia Cancer Agency

Not yet recruiting

Dynamic Whole Body PET/ MRI

Prostatic Cancer

Canada
British Columbia Cancer Agency

Recruiting

Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

Prostatic Neoplasms | Prostate Cancer | Neuroendocrine Tumors | Neuroblastoma | Carcinoid Tumor | Paraganglioma

Canada
British Columbia Cancer Agency

Recruiting

Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease (OPTiMAL)

Prostate Cancer

Canada
British Columbia Cancer Agency

Active, not recruiting

Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant (PBSI)

Early Stage Breast Cancer

Canada
British Columbia Cancer Agency

Active, not recruiting

Volumetric Modulated Arc Therapy (VMAT) for Brain Metastases

Brain Metastases

Canada
British Columbia Cancer Agency

Completed

MSG Use With 18F-DCFPyL PET/CT Imaging

Prostate Cancer | Prostate Cancer Metastatic | Prostatic Neoplasm

Canada
British Columbia Cancer Agency

Terminated

PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer

Breast Cancer

Canada
British Columbia Cancer Agency

Completed

CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using Vitesse (Vitesse)

Prostate Cancer | Interstitial Radiation | High Dose Rate Brachytherapy | Ultrasound-based Planning Compared to CT-based Planning

Canada
Environmental Protection Agency (EPA)

Completed

Effects of Sequential Exposure to Nitrogen Dioxide and Ozone in Healthy Adult Human Volunteers. (ENDZONE)

Respiratory Depression

United States
British Columbia Cancer Agency

Completed

Sequencing Abiraterone and Enzalutamide in mCRPC

Metastatic Castration-Resistant Prostate Cancer

Canada
British Columbia Cancer Agency

Completed

Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy

Prostate Cancer

Canada
British Columbia Cancer Agency

Terminated

Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients

Cancer | Constipation

Canada
British Columbia Cancer Agency

Terminated

CEST- Glucose Enhanced MRI for Metastatic Brain Tumours

Metastasis | Brain Neoplasms, Malignant

Canada
British Columbia Cancer Agency

Unknown

Intensity Modulated Versus Interstitial - Radiation Therapy

Prostate Cancer

Canada

Clinical Trials Sponsored by Agensys, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations